Categories: News

Net Medical Begins Covid Testing on Behalf of New Mexico Department of Health

Leaning on two decades of experience connecting providers with the patients who need them, Net Medical’s business is unique and growing.

ALBUQUERQUE, NM / ACCESSWIRE / February 7, 2022 / Net Medical Xpress Solutions (OTC PINK:NMXS) announced today it has begun Covid testing under an agreement with the State of New Mexico Department of Health.

Under the terms of the agreement, NMXS is:

  • Providing both rapid antigen and PCR tests at a variety of sites.
  • Providing a licensed physician for Covid testing.
  • Providing CLIA (Clinical Laboratory Improvement Amendments) certified laboratory facilities to process and analyze test specimens.
  • Staffing and equipping a project management hub, laboratory, and mobile testing units with a capacity of 700 persons to be tested per day.
  • Providing fully equipped mobile testing teams with a minimum of two persons per team for the region.
  • Providing a copy of certified results from our CLIA certification to each person tested.

Net Medical Chief Medical Officer (CMO) Dr. Neeraj Dubey, MD said, “We are delighted to be providing COVID testing services for the state of New Mexico. Our mobile testing vans are operating successfully in Albuquerque and Taos. This is an important activity for our company and, ultimately, for our shareholders as it is already contributing to increases in revenue and cash flow.”

Net Medical is providing COVID-19 testing at Wilson Stadium in Albuquerque in cooperation with Albuquerque Public Schools and Sagebrush Inn and Suites in Taos as well as other locations.

For more information, call 505-255-1999. X 320. Visit www.netmedical.com. Email ir@netmedical.com

Net Medical partners with state departments of health, healthcare facilities, hospitals and clinics to provide extensive and unique customized solutions for the rapidly expanding multi-billion dollar telemedicine and testing industries. Understanding the complex and evolving needs of serving rural, regional, and high-risk populations, Net Medical has a long legacy of working with healthcare organizations to quickly create solutions that meet their immediate needs:

  • Providing access to care, keeping patients within hospital walls
  • Providing complete care, anywhere – without the patient’s need to travel
  • Sustaining and growing revenue to continue viability in serving their communities

About Net Medical Labs, Inc.

Net Medical’s proprietary suite of services include Telemed platform, electronic medical records interoperability, state-of-the-art conferencing and communications, a call center, unique hardware implementations, and advanced research and development capabilities. No other telemedicine company offers the same extensive and integrated menu of telemedicine and laboratory services as Net Medical, allowing each healthcare organization the ability to custom-create an integrated solution that works for them.

SOURCE: Net Medical Xpress Solutions, Inc.

View source version on accesswire.com:
https://www.accesswire.com/687018/Net-Medical-Begins-Covid-Testing-on-Behalf-of-New-Mexico-Department-of-Health

Staff

Recent Posts

Med Holdings Group, Inc. (FKA Yuka Group, Inc.) Announces Acquisition Of Medsmart Wellness Centers, Inc.

DENVER, CO / ACCESSWIRE / March 22, 2024 / (OTC Pink:YUKA) Med Holdings Group, Inc.…

15 mins ago

GE HealthCare Announces Cash Dividend for First Quarter of 2024

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a…

3 hours ago

GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024

Multi-modality showcase brings hands-on experience to care delivery for a wide range of vascular diseases…

3 hours ago

Smartsheet Names Katie Rooney to Board of Directors

Experienced global CFO adds depth in financial strategy and operating excellence to Smartsheet boardBELLEVUE, Wash.--(BUSINESS…

3 hours ago

The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation

The Centers for Medicare & Medicaid Services revise the National Coverage Determination of allogeneic hematopoietic…

3 hours ago

Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A

Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash. (March…

4 hours ago